Date published: 2026-7-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

HS3ST6 CRISPR/Cas9 KO Plasmid (h): sc-408948

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • HS3ST6 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
  • gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the HS3ST6 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
  • The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    HS3ST6 CRISPR/Cas9 KO Plasmid (h)

    sc-408948
    20 µg
    $397.00

    Overview

    HS3ST6 encodes heparan sulfate-glucosamine 3-O-sulfotransferase 6, a Golgi-localized enzyme that catalyzes 3-O-sulfation of heparan sulfate chains, generating rare sulfation motifs that shape heparan sulfate–protein interactions. By modulating the fine structure of heparan sulfate proteoglycans, HS3ST6 influences ligand binding and gradient formation in extracellular matrix and cell-surface signaling contexts, affecting processes such as cell adhesion, migration, and receptor-mediated signaling. Altered heparan sulfate sulfation patterns are linked to dysregulated growth factor and cytokine signaling and have been associated with tumor biology and inflammatory microenvironments, making HS3ST6 a useful target for mechanistic studies of glycosaminoglycan-dependent regulation.

    HS3ST6 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HS3ST6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HS3ST6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.

    The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HS3ST6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish HS3ST6 protein expression.

    This CRISPR knockout system enables efficient generation of HS3ST6-deficient cell models for investigation of HS3ST6 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.

    Key Features

    • sgRNAs targeting HS3ST6 exon(s) critical for HS3ST6 function
    • Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
    • GFP reporter for identification of transfected cells
    • Pool of plasmids targeting multiple HS3ST6 genomic sites to improve knockout efficiency
    • Compatible with delivery by transfection

    Design Variants

    CRISPRs +/- HDRs

    • gRNAs encoded by HS3ST6 CRISPR/Cas9 KO Plasmid (h) and HS3ST6 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the HS3ST6 locus. One or both targeting designs may be available. See Related Products for availability.
    • HDR donor constructs encoded by HS3ST6 HDR Plasmid (h) and HS3ST6 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by HS3ST6 homology arms to support homology-directed repair at defined HS3ST6 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.